-
Mashup Score: 0Preimplantation Genetic Diagnosis Counseling in Autosomal Dominant Polycystic Kidney Disease - 2 year(s) ago
Autosomal dominant polycystic kidney disease (ADPKD) is one of the most common hereditary forms of chronic kidney disease. Mutations within PKD1 or PKD2 lead to innumerable fluid-filled cysts in the kidneys and in some instances, end-stage renal disease (ESRD). Affected individuals have a 50% chance of passing the mutation to each of their offspring. Assisted reproductive technology using…
Categories: Latest Headlines, NephrologyTweet
-
Mashup Score: 0Charles Vega, MD: Atrial Fibrillation, Risk Factors for Autosomal Dominant Polycystic Kidney Disease - 2 year(s) ago
An interview with Dr. Vega regarding atrial fibrillation and clinical manifestations for ADPKD.
Source: HCPLive®Categories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 2
Tolvaptan is associated with risk of drug-induced liver injury (DILI) when used to treat autosomal dominant polycystic kidney disease (ADPKD). After this risk was described based on the clinical trials TEMPO 3:4 and TEMPO 4:4, additional data from the REPRISE Study and a long-term extension of TEMPO 4:4, REPRISE, and other tolvaptan trials in ADPKD have become available. To further characterize…
Categories: Latest Headlines, NephrologyTweet
-
Mashup Score: 7Is Metformin Now in Our Armamentarium for Autosomal Dominant Polycystic Kidney Disease (ADPKD)? - 2 year(s) ago
Orhan Efe @OrhanEfe_ Dr. Orhan Efe is a Nephrologist at Massachusetts General Hospital in Boston, MA. Dr. Efe was an AJKD Editorial Intern from 2021-2022. He is passionate about glomerular diseases…
Source: AJKD BlogCategories: Latest Headlines, NephrologyTweet
-
Mashup Score: 14Metformin Therapy in Autosomal Dominant Polycystic Kidney Disease: A Feasibility Study - 2 year(s) ago
Autosomal dominant polycystic kidney disease (ADPKD) is a common inherited disorder that leads to kidney failure and has few treatment options. Metformin is well tolerated and safe in other patient populations. The primary objective of this clinical trial was to determine the safety and tolerability of metformin in patients with ADPKD and without diabetes mellitus.
Categories: Hem/Oncs, Latest HeadlinesTweet-
RT @AJKDonline: Metformin Therapy in Autosomal Dominant Polycystic Kidney Disease: A Feasibility Study https://t.co/OPLpA3RJdB @michelcho…
-
-
Mashup Score: 3Metformin Therapy in Autosomal Dominant Polycystic Kidney Disease: A Feasibility Study - 2 year(s) ago
Autosomal dominant polycystic kidney disease (ADPKD) is a common inherited disorder that leads to kidney failure and has few treatment options. Metformin is well tolerated and safe in other patient populations. The primary objective of this clinical trial was to determine the safety and tolerability of metformin in patients with ADPKD and without diabetes mellitus.
Categories: Latest Headlines, NephrologyTweet
-
Mashup Score: 0ADPKD risk factors | MDedge Internal Medicine - 2 year(s) ago
Quiz Fast Facts Friday, January 14th, 2022 Take Quiz Fast…
Source: www.mdedge.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 12NEJM Evidence : - 3 year(s) ago
Original Article Prescribed Water Intake in Autosomal Dominant Polycystic Kidney DiseaseGopala K. Rangan, Ph.D. and OthersIn patients with autosomal dominant polycystic kidney disease (ADPKD), drinking more water could potentially reduce urine osmolality and suppress arginine vasopressin release and decrease the rate of kidney cyst growth and its associated organ…
Source: evidence.nejm.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
Prescribed water intake alone is not associated with slowing growth of #ADPKD cysts. #KidneyWk @gopi_rangan @gopi_rangan @PKDFoundation @gratefull080504 #PKD https://t.co/kX9dWyivBo via @NEJMEvidence
-
-
Mashup Score: 0'Heaviest' kidneys removed in high-risk operation - 3 year(s) ago
Warren Higgs speaks before and after having his kidneys, which weighed more than five stone (35kg), removed.
Source: BBC NewsCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 4Metformin Therapy in Autosomal Dominant Polycystic Kidney Disease: A Feasibility Study - 3 year(s) ago
Autosomal dominant polycystic kidney disease (ADPKD) is a common inherited disorder that leads to kidney failure and has few treatment options. Metformin is well tolerated and safe in other patient populations. The primary objective of this clinical trial was to determine the safety and tolerability of metformin in patients with ADPKD and without diabetes mellitus.
Categories: Latest Headlines, NephrologyTweet
From our Pregnancy and Kidney Disease collection: Preimplantation Genetic Diagnosis Counseling in Autosomal Dominant Polycystic Kidney Disease https://t.co/W9SJh5LICl (FREE temporarily) @ndahl48 @YaleNephrology #ADPKD https://t.co/ZzwXIrXmLy